Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas

This publication has 19 references indexed in Scilit:

• Tumor Oxygenation: A New Predictive Parameter in Locally Advanced Cancer of the Uterine Cervix
  Gynecologic Oncology, 1993
• First analysis on tumor regression for the European randomized trial of etanidazole combined with radiotherapy in head and neck carcinomas
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Logistics in designing clinical trials for etanidazole (SR 2508): An RTOG experience
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Failure of misonidazole-sensitized radiotherapy to impact upon outcome among stage III–IV squamous cancers of the head and neck
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Late results of a trial of hyperbaric oxygen and radiotherapy in head and neck cancer: A rationale for hypoxic cell sensitizers?
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule
  International Journal of Radiation Oncology*Biology*Physics, 1986
• Clinical trials of radiosensitizers: What should we expect?
  International Journal of Radiation Oncology*Biology*Physics, 1984
• SR-2508: A 2-nitroimidazole amide which should be superior to misonidazole as a radiosensitizer for clinical use
  International Journal of Radiation Oncology*Biology*Physics, 1981
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958